Leire explains to Proactive there are two reasons to be excited by the partnership.
Using organoids means fewer animals are used for testing, which will speed up the development process.
Secondly, the agreement involves a lot of activities regarding reprogramming and partial reprogramming of cells.
“This is the hottest area in longevity currently,” he says.